China Merchants Bank (03968): Zhang Yong's qualification to serve as an independent non-executive director has been approved.
China Merchants Bank (03968) has announced that it has received the "Approval from the National Financial Supervisory Administration regarding Zhang Yong's Qualifications as an Independent Director of China Merchants Bank" (Jin Fu [2026] No. 496). According to the above approval, Mr. Zhang Yong's qualifications as an independent director of China Merchants Bank have been approved. Mr. Zhang Yong's term as an independent non-executive director will take effect from September 8, 2026, and will continue until the end of the company's 13th Board of Directors' term.
China Merchants Bank (03968) announced that it has received the "Approval from the National Financial Regulatory Administration regarding the Appointment Qualifications of Mr. Zhang Yong as an Independent Director of China Merchants Bank" (Jin Fu [2026] No. 496). According to the approval, Mr. Zhang Yong's qualifications as an independent director of China Merchants Bank have been confirmed. His term as an independent non-executive director of the company will take effect from September 8, 2026, until the end of the companys thirteenth board of directors.
In addition, effective September 8, 2026, based on the proposal reviewed and approved at the eighteenth meeting of the thirteenth board of directors regarding the adjustment of the composition of the board's special committee members: Mr. Zhang Yong will serve as a member of the Boards Strategy and Sustainable Development Committee and as the Chairman of the Boards Compensation and Assessment Committee; Mr. Huang Yushan will be a member of the Boards Compensation and Assessment Committee and will no longer serve as the Chairman of that committee.
Related Articles

YUEXIUTRANSPORT (01052): Liu Yan appointed as Chairman.

Henan Yuneng Holdings (001896.SZ) plans to increase the capital of its subsidiary Lushan Pumped Storage by 340 million yuan.

HBM HOLDINGS-B (02142): Positive interim results from the Phase II clinical trial of HBM9378/WIN378 for the treatment of asthma and the initiation of Phase III study.
YUEXIUTRANSPORT (01052): Liu Yan appointed as Chairman.

Henan Yuneng Holdings (001896.SZ) plans to increase the capital of its subsidiary Lushan Pumped Storage by 340 million yuan.

HBM HOLDINGS-B (02142): Positive interim results from the Phase II clinical trial of HBM9378/WIN378 for the treatment of asthma and the initiation of Phase III study.

RECOMMEND





